Katie Kingwell

1.6k total citations
168 papers, 1.1k citations indexed

About

Katie Kingwell is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Katie Kingwell has authored 168 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 29 papers in Physiology and 25 papers in Cellular and Molecular Neuroscience. Recurrent topics in Katie Kingwell's work include Alzheimer's disease research and treatments (14 papers), CRISPR and Genetic Engineering (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Katie Kingwell is often cited by papers focused on Alzheimer's disease research and treatments (14 papers), CRISPR and Genetic Engineering (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Katie Kingwell collaborates with scholars based in United States. Katie Kingwell's co-authors include and has published in prestigious journals such as Nature reviews. Neuroscience, Nature reviews. Immunology and Nature Reviews Drug Discovery.

In The Last Decade

Katie Kingwell

158 papers receiving 1.1k citations

Peers

Katie Kingwell

MB

CMN

PHYSI

ONCOL

NEURO

Ning Yao China

Antonio Gaballo Italy

Seigo Suzuki Japan

So Young Jang South Korea

Hiroki Otsuka Japan

Caroline May Germany

Andrea Bileck Austria

Qing Xin China

Bjarne Krebs Germany

Bjørn Ivar Haukanes Norway

Ning Yao China

Katie Kingwell

486 ×1.0

MB

168 ×0.9

CMN

76 ×0.4

PHYSI

69 ×0.7

ONCOL

111 ×1.1

NEURO

Citations per year, relative to Katie Kingwell Katie Kingwell (= 1×) peers Ning Yao

Countries citing papers authored by Katie Kingwell

Since Specialization

Citations

This map shows the geographic impact of Katie Kingwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie Kingwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie Kingwell more than expected).

Fields of papers citing papers by Katie Kingwell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie Kingwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie Kingwell. The network helps show where Katie Kingwell may publish in the future.

No nodes

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Kingwell, Katie. (2024). Rebalancing calcium in Alzheimer disease. Nature Reviews Drug Discovery. 23(8). 580–580. 1 indexed citations

2.

Kingwell, Katie. (2024). WRN inhibitors squeeze cancer cell vulnerability. Nature Reviews Drug Discovery. 23(6). 419–419. 1 indexed citations

3.

Kingwell, Katie. (2024). New NIH director’s research agenda spans “the laboratory, the clinic and the community”. Nature Reviews Drug Discovery. 23(3). 166–167.

4.

Kingwell, Katie. (2024). Splice-switching ASO curtails brain calcification. Nature Reviews Drug Discovery. 23(10). 742–742.

5.

Kingwell, Katie. (2023). A new shuttle for drug delivery across the blood–brain barrier. Nature Reviews Drug Discovery. 22(12). 952–952. 3 indexed citations

6.

Kingwell, Katie. (2023). γ-secretase inhibitor notches first approval. Nature Reviews Drug Discovery. 23(1). 9–9. 1 indexed citations

7.

Kingwell, Katie. (2023). Microbial ‘dark matter’ yields new antibiotic. Nature Reviews Drug Discovery. 22(11). 872–872. 3 indexed citations

8.

Kingwell, Katie. (2022). LRRK2-targeted Parkinson disease drug advances into phase III. Nature Reviews Drug Discovery. 22(1). 3–5. 15 indexed citations

9.

Kingwell, Katie. (2022). Base editors hit the clinic. Nature Reviews Drug Discovery. 21(8). 545–547. 42 indexed citations

10.

Kingwell, Katie. (2021). Navigating a new path to Nav1.7 for pain. Nature Reviews Drug Discovery. 21(1). 18–18. 6 indexed citations

11.

Kingwell, Katie. (2021). Exploring new frontiers in multiple sclerosis. Nature Reviews Drug Discovery. 20(11). 815–815. 1 indexed citations

12.

Kingwell, Katie. (2019). Nav1.7 withholds its pain potential. Nature Reviews Drug Discovery. 18(5). 321–323. 56 indexed citations

13.

Kingwell, Katie. (2018). Translational target for checkpoint inhibitors. Nature reviews. Immunology. 18(12). 728–729. 2 indexed citations

14.

Kingwell, Katie. (2016). Two-pronged attack on HIV. Nature reviews. Immunology. 16(8). 465–465. 2 indexed citations

15.

Kingwell, Katie. (2016). Multifaceted approach to multidrug resistance. Nature Reviews Drug Discovery. 15(11). 750–750. 1 indexed citations

16.

Kingwell, Katie. (2014). A new weapon against metastatic melanoma. Nature Reviews Drug Discovery. 13(5). 334–335. 3 indexed citations

17.

Kingwell, Katie. (2013). Glioblastoma prognosis linked to neuronal PD-L1 expression in tumour-adjacent tissue. Nature Reviews Neurology. 9(11). 602–603. 11 indexed citations

18.

Kingwell, Katie. (2012). New insights into preclinical Alzheimer disease. Nature Reviews Neurology. 9(1). 4–4. 2 indexed citations

19.

Kingwell, Katie. (2012). Measures of functional brain connectivity can be used to predict outcome after glioma surgery. Nature Reviews Neurology. 8(10). 532–532. 2 indexed citations

20.

Kingwell, Katie. (2009). Seeing the potential of targeting CCR3. Nature Reviews Drug Discovery. 8(8). 614–614. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact